Health
Researchers inch closer to more precise treatment for patients with type 1 diabetes – Mental Daily
The new findings could prove to be a major step towards ensuring that patients with diabetes receive the exact right amount of insulin.
A coalition of experts at the University of Copenhagen and the biotech company Gubra have unveiled an insulin molecule capable of self-regulating blood sugar for patients with type 1 diabetes.
The study appeared in Chemistry – A European Journal.
The new findings could prove to be a major step towards ensuring that patients with diabetes receive the exact right amount of insulin.
The insulin molecule was tested on rodents first and demonstrated efficiency for detecting blood sugar is in the body,…
Continue Reading
